Critical review: Pattern of Presentation of Bhringaraja (Eclipta alba Linn.) in Nighantu Era
DOI:
https://doi.org/10.70066/jahm.v11i3.766Keywords:
Bhringaraja, Eclipta alba Linn., Nighantu, Dravyaguna, Paryaya, Rasapanchaka.Abstract
Nighantu are essential for understanding of medicinal plants in Ayurveda specially in Dravyaguna Vijyana. They are as ancient as other Ayurvedic Samhita and used since Vedic periods to understand the meanings of the unknown words. They are very rich in knowledge of synonyms, properties, actions, etc. Bhringaraja is renowned and explored plant since Vedic periods. It is used as Keshya, Rasayana, Twachya, etc. In this article, we assembled and classified evidences regarding Paryaya, Rasapanchaka, Rogaghnata of Bhringaraja from various Nighantu in scientific way. This article offers more opportunity to study Bhringaraja in various condition.
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Krima B. Patel, Dilip K. Jani, Suman G, Singh, Kevina M. Patel

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.